Cosmos Health (NASDAQ:COSM) Stock Bumped Up to “Hold” by Wall Street Zen

Cosmos Health (NASDAQ:COSM) was upgraded by Wall Street Zen to a “hold” rating in a report released on Saturday, Wall Street Zen reports.

Other analysts also recently issued reports about the stock. Noble Financial initiated coverage on shares of Cosmos Health in a research report on Monday, October 26th. They issued an “outperform” rating for the company. Weiss Ratings restated a “sell (d-)” rating on shares of Cosmos Health in a report on Wednesday, October 28th. One research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold”.

Cosmos Health Price Performance

Shares of Cosmos Health stock opened at $3.24 on Friday. The stock has a 50-day simple moving average of $6.06 and a 200-day simple moving average of $5.98. Cosmos Health has a 52-week low of $3.00 and a 52-week high of $15.40. The company has a current ratio of 1.05, a quick ratio of 0.92 and a debt-to-equity ratio of 0.15.

Cosmos Health (NASDAQ:COSM) last released its quarterly earnings data on Tuesday, August 18th. The company reported ($2.00) EPS for the quarter, hitting analysts’ consensus estimates of ($2.00). The firm had revenue of $19.32 million for the quarter, compared to the consensus estimate of $18.99 million. Cosmos Health had a negative return on equity of 56.88% and a negative net margin of 33.08%. On average, research analysts anticipate that Cosmos Health will post -0.15 EPS for the current fiscal year.

Institutional Investors Weigh In On Cosmos Health

A hedge fund recently bought a new position in Cosmos Health stock. BlackRock Inc. bought a new position in shares of Cosmos Health Inc. (NASDAQ:COSM) in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 267,797 shares of the company’s stock, valued at approximately $49,000. BlackRock Inc. owned 0.45% of Cosmos Health as of its most recent SEC filing. Institutional investors and hedge funds own 12.61% of the company’s stock.

Cosmos Health Company Profile

Cosmos Health Inc. is a healthcare group that develops, manufactures and distributes pharmaceutical, nutraceutical and healthcare products. Its portfolio includes branded dietary supplements, vitamins and wellness products, as well as pharmaceutical products and medical devices distributed through retail, wholesale and online channels. The company markets its nutraceutical products under the Sky Premium Life brand, which offers supplements and other health and wellness products. Cosmos Health also has manufacturing and product-development activities through Cana Laboratories, a Greece-based pharmaceutical manufacturer that produces pharmaceutical and healthcare products for its own portfolio and third parties.